Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study

Author(s):
Heijde, D. van der; Deodhar, A.A.; Wei, J.C.; Drescher, E.; Fleishaker, D.; Hendrikx, T.; Li, D.; Menon, S.; Kanik, K.S.
Published
2015
Publication type
Article / Letter to editor
Date issued
2015-10-31
Language
English
Is part of
Arthritis and Rheumatology
hdl
1887/114320